Pharmocann Global Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
PMCN
IL0010968902
Healthcare Facilities & Services
Sales 2022 | 22.66M 6.11M 481M | Sales 2023 | 14.41M 3.89M 306M | Capitalization | 3.12M 841K 66.32M |
---|---|---|---|---|---|
Net income 2022 | -25M -6.74M -531M | Net income 2023 | -9M -2.43M -191M | EV / Sales 2022 | 0.4 x |
Net cash position 2022 | 925K 249K 19.65M | Net cash position 2023 | 768K 207K 16.32M | EV / Sales 2023 | 0.16 x |
P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 16/06/19 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 28/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 04/12/22 |
Locar Gila
BRD | Director/Board Member | 51 | 28/11/22 |
Director/Board Member | 43 | 28/11/22 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
-38.84% | 335M | |
+60.49% | 316M | |
+41.24% | 291M | |
+60.47% | 210M | |
+56.54% | 142M | |
+140.77% | 137M | |
+46.15% | 128M | |
-28.57% | 121M |